Viewing Study NCT00044512


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2026-02-04 @ 8:37 PM
Study NCT ID: NCT00044512
Status: COMPLETED
Last Update Posted: 2014-04-16
First Post: 2002-08-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Liver Cancer View
None Hepatocellular carcinoma (HCC) View